Amirul (not his real name) was offered an e-vaporiser by his friend in September, and took a puff without thinking much about it.
On his friend's urging, the 21-year-old student took another puff, and this time, his body felt heavy and his head began to spin.
While these effects lasted only a minute, he became upset upon learning from his friend that the vape had been laced with drugs.
"I was told that the vape I took was known as a Kpod," he told The Straits Times.
Kpods - vape juice that is usually mixed with etomidate, an anaesthetic used in some non-surgical procedures - are a growing scourge in Singapore, according to some social service agencies here.
They told ST that they have seen an increase in people aged between 12 and 19 discussing and participating in this latest vape trend.
Etomidate is classified as a poison under the Poisons Act, and a licence is needed to import or sell it here.
Checks by ST showed that there were at least six groups selling Kpods on messaging app Telegram, some with hundreds of members. Some groups even offered promises to deliver the products within half an hour.
Some sellers in the Telegram groups claimed they also sell vape liquid with ketamine. Ketamine, which can be used as an anaesthetic in emergency care for pain relief or short surgical procedures, is listed as a Class A controlled drug in Singapore. It is illegal to traffic, make, import, export, possess or consume the drug.
Prices of such drug-laced vapes range from $50 to $100, according to social workers whom ST spoke to, as well as prices listed in the Telegram groups. A normal vape costs between $10 and $70.
When contacted, the Health Sciences Authority (HSA) said that it, along with the Central Narcotics Bureau (CNB), is monitoring the trend of using vapes to consume illegal substances, which has also been observed overseas.
This story is from the December 16, 2024 edition of The Straits Times.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 16, 2024 edition of The Straits Times.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In

Buying a handbag or an experience? Brands are raising the retail bar
In an era of immersive shopping, it's not just about a product, but how you feel while buying it.

Dropped Smith still England 'game changer'
England coach Steve Borthwick insists Marcus Smith can remain a \"game changer\" despite dropping him to the bench for the Six Nations clash against Italy at Twickenham on March 9.

CREATIVE CROSSOVER
Prominent brands are appointing celebrities in creative positions, reshaping the intersection between sports, music and fashion

DBS chief's 2024 pay rises to $17.6m after bank's record performance
Full-year net profit rises 11% to $11.4 billion, with return on equity at 18% in 'stellar' year
Trump's Tariff Turbulence Is Worse Than Anyone Imagined
Even his concessions are less generous than expected.

India speeds up free trade talks with Western nations amid US tariff threats
Delhi seeks deals with Britain, EU as access to major markets is set to get complicated
SGX revamps leadership in FX, technology teams amid push to revive stock market
The Singapore Exchange (SGX) has revamped its foreign exchange (FX) and technology management teams, following several high-level resignations.

'Frustrated' Bezecourt keen to stop Geylang's bleeding
From the trail of blood leading from the corridor to the living room, bedroom and bathroom, Geylang International midfielder Vincent Bezecourt's condominium looked more sinister than it really was.

'Big Moment' For Elliott
Sub nets Reds' late winner in Paris as Slot says they were lucky to even earn a draw

Passion Fuels James' Records
Oldest Player of the Month winner crosses 50,000-point mark as Lakers keep winning